bioRxivBioinformaticsPreprint
Benchmarking Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective Inhibition
Alejandro FeitoiD, Natàlia DeMoya‐ValenzuelaiD, Cristian PrivatiD, Andrés R. TejedoriD, Marco DelValle-CarrilloiD, Sara CembellíniD, Lucía Paniagua‐Herranz, Adiran GaraizariD, J. Oller-IscariD, Alberto OcanaiD, Jorge R. EspinosaiD
Abstract
Accurate prediction of inhibitor selectivity across protein paralogues remains a central challenge in computational drug discovery. Here, we systematically benchmark three computational methods--Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA), free energy perturbation (FEP) and potential of mean force (PMF) calculations--in their ability to recapitulate PARP1 versus PARP2 selectivity for eight clinically relevant PARP enzyme inhibitors used in ovarian, breast and prostate tumors among others. We demonstrate how MM/PBSA calculations offer rapid and qualitative insights, but show pronounced sensitivity to the chosen static conformational pose, being particularly challenging for ligands with subtle energetic differences between distinct protein paralogues. In contrast, both FEP and PMF calculations using atomistic models with explicit solvent result in substantially improved agreement with experimental binding affinities. The FEP method exhibits the strongest quantitative correlation with experimental binding free energy differences, remarkably reproducing selectivity trends even among nearly isoenergetic complexes. Notably, our structural contact analysis reveals how contact connectivity controls ligand selectivity, providing valuable mechanistic and molecular insight into the key residues that stabilize each inhibitor in both protein enzymes. Together, our multi-method computational study contributes to elucidate potential chemical modifications across the ligand chemical space to enhance potency and specificity, informing the future design and evaluation of selective inhibitors for precision oncology, including therapies targeting homologous recombination-deficient cancers.
- research focus: benchmarking
- research focus: drug response / drug discovery
- research focus: perturbation response prediction
- approach: statistical model
- approach: simulation
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cooperative molecular interaction networks govern PARP1 inhibitor selectivity and binding affinity
Alejandro Feito, Natàlia DeMoya‐Valenzuela, … Jorge R. Espinosa·PLoS Computational BiologyPeer-reviewed·May 26, 2026
- Duplexed CeTEAM drug biosensors reveal determinants of PARP inhibitor selectivity
Maria Joao Almeida A Silva Pires, Seher Alam, … Nicholas C.K. Valerie·Journal of Biological ChemistryPeer-reviewed·Feb 26, 2025
- Selectivity profile of the poly(ADP-ribose) polymerase (PARP) inhibitor, A-966492
Ann-Gerd Thorsell, Herwig Schüler·bioRxiv·Mar 23, 2017
- Prediction of Accurate Binding Modes using Combination of classical and accelerated Molecular dynamics and Free Energy Perturbation Calculations: An Application to Toxicity Studies
F. Fratev, Thomas B. Steinbrecher, Svava Ósk Jónsdóttir·ACS OmegaPeer-reviewed·Apr 20, 2018
- De novo design of drug-binding proteins with predictable binding energy and specificity
L. Lu, X. Gou, … W. DeGrado·bioRxiv·Dec 23, 2023
- Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors
Klaudia Caba, Viet‐Khoa Tran‐Nguyen, … Pedro J. Ballester·Journal of CheminformaticsPeer-reviewed·Apr 6, 2024